ThermoGenesis Holdings, Inc.
(NASDAQ : KOOL)

( )
KOOL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.98%628.331.0%$845.71m
DHRDanaher Corp. 2.13%313.450.7%$787.97m
MDTMedtronic Plc 1.82%112.250.6%$721.69m
ABTAbbott Laboratories -0.03%132.430.8%$684.68m
ISRGIntuitive Surgical, Inc. 5.16%340.490.8%$527.81m
DXCMDexCom, Inc. 6.48%558.407.8%$419.12m
BDXBecton, Dickinson & Co. 1.73%250.391.0%$383.76m
SYKStryker Corp. 2.41%260.541.3%$373.40m
BSXBoston Scientific Corp. 1.72%41.401.0%$362.00m
ALGNAlign Technology, Inc. 4.35%666.726.4%$339.55m
EWEdwards Lifesciences Corp. 3.22%115.560.4%$288.80m
AAgilent Technologies, Inc. 1.63%153.941.6%$259.09m
ZBHZimmer Biomet Holdings, Inc. 2.33%128.411.7%$232.19m
IDXXIDEXX Laboratories, Inc. 3.25%611.433.8%$226.28m
PKIPerkinElmer, Inc. (United States) 2.16%185.402.4%$173.66m

Company Profile

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.